Literature DB >> 24853949

Physicochemical modifications of histones and their impact on epigenomics.

Federico Andreoli1, Alberto Del Rio2.   

Abstract

The study of histone post-translational modifications (PTMs) has made extraordinary progress over the past few years and many epigenetic modifications have been identified and found to be associated with fundamental biological processes and pathological conditions. Most histone-modifying enzymes produce specific covalent modifications on histone tails that, taken together, elicit complex and concerted processes. An even higher level of complexity is generated by the action of small molecules that are able to modulate pharmacologically epigenetic enzymes and interfere with these biochemical mechanisms. In this article, we provide an overview of histone PTMs by reviewing and discussing them in terms of their physicochemical properties, emphasizing these concepts in view of recent research efforts to elucidate epigenetic mechanisms and devise future epigenetic drugs.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2014        PMID: 24853949     DOI: 10.1016/j.drudis.2014.05.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  5 in total

1.  3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.

Authors:  Craig J Kutz; Steven L Holshouser; Ethan A Marrow; Patrick M Woster
Journal:  Medchemcomm       Date:  2014-12       Impact factor: 3.597

Review 2.  PWWP domains and their modes of sensing DNA and histone methylated lysines.

Authors:  Germana B Rona; Elis C A Eleutherio; Anderson S Pinheiro
Journal:  Biophys Rev       Date:  2016-01-14

Review 3.  Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes.

Authors:  Federico Andreoli; Alberto Del Rio
Journal:  Comput Struct Biotechnol J       Date:  2015-05-07       Impact factor: 7.271

Review 4.  Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension.

Authors:  Yu Wang; Lingling Yan; Ziming Zhang; Eric Prado; Linchen Fu; Xuefeng Xu; Lizhong Du
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

Review 5.  Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension.

Authors:  Linh Ho; Nazir Hossen; Trieu Nguyen; Au Vo; Fakhrul Ahsan
Journal:  Biomedicines       Date:  2022-01-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.